西班牙儿童和青少年自身免疫性脑炎的鉴别诊断及诊断算法比较:前瞻性队列研究与回顾性分析
研究纳入西班牙40家医院的729例疑似自身免疫性脑炎患儿,前瞻性随访至少2年,比较通用与儿科两种国际诊断算法。抗体阳性者两算法一致性极好(kappa 0.99),经验性免疫治疗推荐一致性良好(0.59), probable抗体阴性诊断一致性差(0.29);儿科算法纳入更多 probable抗体阴性患者(173 vs 41)。
要点
- 约三分之一疑似自身免疫性脑炎患儿最终确诊该病或其他明确炎症性疾病。
- 常见模拟病包括感染、癫痫和精神疾病。
- 两算法诊断抗体阳性自身免疫性脑炎一致性极好(kappa 0.99)。
核心结论
- 约三分之一疑似自身免疫性脑炎患儿最终确诊该病或其他明确炎症性疾病。
- 常见模拟病为感染、癫痫和精神疾病。
- 两算法诊断抗体阳性自身免疫性脑炎表现良好,但儿科算法可能低估无抗体 definite自身免疫性脑炎并过度诊断 probable抗体阴性患者,通用算法可能诊断不足。
- probable抗体阴性自身免疫性脑炎诊断不准确可导致免疫治疗过度或不足。
研究设计与样本
- 前瞻性队列研究,纳入西班牙40家医院所有小于18岁的疑似自身免疫性脑炎患者,医生每6个月提供临床信息,随访至少2年。
- 抗体检测在巴塞罗那August Pi i Sunyer生物医学研究所-临床医院进行。
- 按末次随访最可能诊断分为四个预设类别。
- 采用多变量logistic分析评估 probable抗体阴性患者中免疫治疗与结局的潜在关联。
- 回顾性分析通用与儿科诊断算法之间的一致性,采用kappa指数评估。
主要发现
- 2013年6月1日至2021年5月31日纳入729例患儿,平均年龄7.1岁(SD 4.9),男孩383例(53%),女孩346例(47%)。
- 中位随访36个月(IQR 26-60)后,definite自身免疫性脑炎或明确炎症/自身免疫性疾病230例(32%),CNS感染112例(15%),不明原因炎症性CNS疾病81例(11%,其中3例(4%)为新发Klüver-Bucy样综合征),非炎症性疾病306例(42%,主要为癫痫或精神疾病177/306(58%))。
- 230例definite自身免疫性脑炎中150例(65%)检出神经抗体,其中127/150(85%)为NMDA受体或髓鞘少突胶质细胞糖蛋白抗体。
- 两算法一致性:抗体阳性自身免疫性脑炎诊断kappa 0.99(95%CI 0.97-1.00),经验性免疫治疗推荐kappa 0.59(95%CI 0.54-0.65), probable抗体阴性自身免疫性脑炎诊断kappa 0.29(95%CI 0.21-0.37)。
- 与通用算法相比,儿科算法纳入更多 probable抗体阴性自身免疫性脑炎患者(173 vs 41),包括末次随访诊断为不明原因炎症性CNS疾病者(儿科算法80/81 vs 通用算法31/81)和非炎症性疾病者(儿科算法47/306 vs 通用算法6/306)。
关键数值与推荐
- 抗体阳性自身免疫性脑炎诊断一致性极好:kappa 0.99(95%CI 0.97-1.00)。
- 经验性免疫治疗推荐一致性良好:kappa 0.59(95%CI 0.54-0.65)。
- probable抗体阴性自身免疫性脑炎诊断一致性差:kappa 0.29(95%CI 0.21-0.37)。
- 儿科算法 vs 通用算法纳入 probable抗体阴性患者:173 vs 41。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The usefulness of current diagnostic approaches in children with suspected autoimmune encephalitis is unknown. We aimed to assess the diagnosis of autoimmune encephalitis in clinical practice and to compare the performance of two international diagnostic algorithms (one intended for patients of any age [general], the other intended for paediatric patients), with particular emphasis on the evaluation of patients with probable antibody-negative autoimmune encephalitis because this diagnosis suggests that immunotherapy should be continued or escalated but is difficult to establish. METHODS: We did a prospective cohort study that included all patients (<18 years of age) with suspected autoimmune encephalitis recruited at 40 hospitals in Spain whose physicians provided clinical information every 6 months for 2 years or more. Neural antibody testing to confirm diagnosis of antibody-positive autoimmune encephalitis was done at Institut d'Investigacions Biomèdiques August Pi i Sunyer-Hospital Clínic, Barcelona. Patients were classified according to the most probable diagnosis at last follow-up into four prespecified categories. We used multivariable logistic analysis to assess a potential association between immunotherapy and outcome in individuals with probable antibody-negative autoimmune encephalitis. We also did a retrospective analysis of agreement, assessed with the kappa index, between diagnoses made according to the general and paediatric diagnostic algorithms. FINDINGS: Between June 1, 2013, and May 31, 2021, 729 children (mean age 7·1 years [SD 4·9]; 383 boys [53%], 346 girls [47%]) with suspected autoimmune encephalitis were recruited. After a median follow-up of 36 months (IQR 26-60), patients were classified according to their most probable diagnosis: definite autoimmune encephalitis or well defined inflammatory or autoimmune disorders (n=230 [32%]); CNS infections (n=112 [15%]); inflammatory CNS disorders of unknown cause (n=81 [11%], including three (4%) with a novel Klüver-Bucy-like syndrome; and non-inflammatory disorders (n=306 [42%]), which were predominantly epileptic or psychiatric disorders (177 [58%] of 306). Neural antibodies were detected in 150 (65%) of 230 patients who had definite autoimmune encephalitis; 127 (85%) of these 150 individuals had antibodies to the NMDA receptor or myelin oligodendrocyte glycoprotein (MOG). Agreement between algorithms was excellent (kappa index 0·99, 95% CI 0·97-1·00) for the diagnosis of children with antibody-positive autoimmune encephalitis, good (0·59, 0·54-0·65) for recommendations of empiric immunotherapy, and poor (0·29, 0·21-0·37) for the diagnosis of probable antibody-negative autoimmune encephalitis. Compared with the general algorithm, the paediatric algorithm included more patients in the probable antibody-negative autoimmune encephalitis category (173 vs 41). These patients included some of those who had a diagnosis of CNS inflammatory disorder of unknown cause at the last follow-up (80 of 81 with the paediatric algorithm vs 31 of 81 with the general algorithm), who might have benefitted from immunotherapy, and some of those diagnosed with a non-inflammatory disorder at the last follow-up (47 of 306 with the paediatric algorithm vs six of 306 with the general algorithm), who did not need immunotherapy. INTERPRETATION: About a third of children with suspected autoimmune encephalitis eventually had confirmation of this diagnosis, or diagnosis of another well defined inflammatory disorder. Frequent mimics of autoimmune encephalitis were infectious, epileptic, and psychiatric disorders. Both algorithms performed well in the diagnosis of antibody-positive autoimmune encephalitis, but the paediatric algorithm under-recognised definite autoimmune encephalitis that can occur without autoantibodies and might have overdiagnosed patients with probable antibody-negative autoimmune encephalitis. By contrast, the general algorithm might have underdiagnosed patients with probable antibody-negative autoimmune encephalitis. Given that the diagnosis of probable antibody-negative autoimmune encephalitis has treatment implications, inaccuracies on this diagnostic category leads to overuse or underuse of immunotherapy. FUNDING: Instituto de Salud Carlos III, Fundació Clínic per la Recerca Biomèdica, The Edmond J Safra Foundation, and la Caixa Foundation. TRANSLATION: For the Spanish translation of the abstract see Supplementary Materials section.
引用
- Olivé-Cirera G, Fonseca E, Chen LW, et al. Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis. Lancet Neurol. 2025. PMID: 39706634. doi:10.1016/S1474-4422(24)00443-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。